Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy

被引：3
|
作者：
Pathak, Vivek [1 ]
Venkatesan, Madhav [1 ]
Regunathan-Shenk, Renu [1 ,2 ]
机构：
[1] Kovai Med Ctr & Hosp, Nephrol, Coimbatore 641014, Tamil Nadu, India
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
KIDNEY360 | 2021年 / 2卷 / 02期
关键词：
clinical nephrology; cyclosporine; membranous glomerulonephritis; remission induction; rituximab; tacrolimus;
D O I：
10.34067/KID.0004672020
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：336 / 338
页数：3
相关论文
共 50 条
  • [1] Low-dose rituximab is poorly effective in patients with primary membranous nephropathy
    Moroni, Gabriella
    Depetri, Federica
    Del Vecchio, Lucia
    Gallelli, Beniamina
    Raffiotta, Francesca
    Giglio, Elisa
    Brunini, Francesca
    D'Amico, Marco
    Longhi, Selena
    Radice, Antonella
    Messa, Piergiorgio
    Sinico, Renato Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (10) : 1691 - 1696
  • [2] Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study
    Chen, Xian
    Jiao, Sumin
    Li, Shaomei
    Li, Juan
    Li, Pei
    Song, Fang
    Yan, Zhe
    BALKAN MEDICAL JOURNAL, 2023, 40 (04) : 287 - 293
  • [3] Efficacy of tacrolimus monotherapy in primary membranous nephropathy
    Zhang, Ya-pu
    Ran, Lei
    Guo, Li
    Gou, Yan-Li
    Guo, Shan-shan
    Xu, Yang
    Hua, Xin
    Chen, Hang
    OPEN MEDICINE, 2024, 19 (01):
  • [4] Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up
    Zonozi, Reza
    Laliberte, Karen
    Huizenga, Noah R.
    Rosenthal, Jillian K.
    Jeyabalan, Anushya
    Collins, A. Bernard
    Cortazar, Frank B.
    Niles, John L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (06) : 793 - 803
  • [5] Combination of ultra-low dose rituximab and low dose tacrolimus versus tacrolimus alone in the treatment of non-responsive idiopathic membranous nephropathy: a Chinese retrospective cohort study
    Zhu, Fan
    Chu, Xiaoxin
    Guo, Yi
    Li, Yinzheng
    Cao, Chujin
    Wu, Jianliang
    Xu, Huzi
    Deng, Xuan
    Li, Junhua
    Liu, Xiaocheng
    Yao, Ying
    Zeng, Rui
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (07): : 7622 - 7631
  • [6] Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
    Cortazar, Frank B.
    Leaf, David E.
    Owens, Charles T.
    Laliberte, Karen
    Pendergraft, William F., III
    Niles, John L.
    BMC NEPHROLOGY, 2017, 18 : 1 - 10
  • [7] Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
    Frank B. Cortazar
    David E. Leaf
    Charles T. Owens
    Karen Laliberte
    William F. Pendergraft
    John L. Niles
    BMC Nephrology, 18
  • [8] Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
    Wang Xiao-Pei
    Hu Zhang-Xue
    Guo Dong-Yang
    Tao Ye
    中华医学杂志英文版, 2016, 129 (07) : 871 - 873
  • [9] Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
    Wang, Xiao-Pei
    Hu, Zhang-Xue
    Guo, Dong-Yang
    Tao, Ye
    CHINESE MEDICAL JOURNAL, 2016, 129 (07) : 871 - 873
  • [10] Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
    Bagchi, Soumita
    Subbiah, Arun Kumar
    Bhowmik, Dipankar
    Mahajan, Sandeep
    Yadav, Raj Kanwar
    Kalaivani, Mani
    Singh, Geetika
    Dinda, Amit
    Agarwal, Sanjay Kumar
    CLINICAL KIDNEY JOURNAL, 2018, 11 (03) : 337 - 341
12345